This invention relates to free radical polymerizable macrocyclic compounds and composition, which feature by their low shrinkage and low contraction stress upon polymerization. Such low shrinkage and low stress resin could find their wide range of applications, especially in microelectronic, special coating and restorative dentistry where the dimensional stability and contraction stress within cured materials are critical to the total performance.
The polymerization shrinkage of curable material is referred to the dimensional contraction during polymerization or curing, because the formation of covalent bonding during polymerization bring the molecules closer each other than that while they are free in van der Walls distance. The origin of polymerization stress, on the other hand, comes from a restrained polymerization or shrinking during curing. Therefore, it is not only related to polymerization shrinkage, but also is dependent on the polymerization kinetics.
It is well known that with increasing molecular weight, the mobility of polymeric chain would be limited, the diffusion is becoming the rate control factor. In addition, such a limited mobility in a cross-linking system appear to come earlier in comparison with linear system, which means extra reaction would lead to an increasing polymerization stress. There are different ways to control the stress generation and development:
1. Slow down the polymerization rate;
2. Reduce the conversion;
3. Limiting the cross-link density to offer acceptable mechanical property.
To reduce polymerization shrinkage and stress in the specific dental restorative composite, all of above approaches are taking into account. In this invention, however, the objective is to present a general method to produce a macrocyclic oligomer which would be converted into 3D network via free radical polymerization.
U.S. Pat. No. 4,644,053, disclosed a method to synthesize single macrocyclic compounds. Then various macrocyclics oligomers, including carbonates, esters, amides, ethers, imides, sulfides, et al, have been prepared. However, high temperature ring-opening reaction has to be involved to convert these macrocyclics into high molecular weight polymers.
U.S. Pat. No. 5,047,261, disclosed a composition containing a five-member carbonate cyclic group for fast copolymerization with methacrylate.
U.S. Pat. No. 5,792,821, disclosed polymerizable cyclidextrin (CD) derivatives, in which methacrylate was attached on CD.
U.S. Pat. No. 5,962,703, disclosed functionalized bicyclic methacrylate with norboneyl or norbonadienl group.
U.S. Pat. No. 6,043,361, disclosed polymerizable cyclic allylic sulfides is used for low shrinkage materials.
The macrocyclic oligomers are prepared under pseudo-high-dilution condition via a condensation between a reactive and free radical polymerizable precursor and various coupling agents to afford carbonate, ester, siloxane, phosphonate, et al linkages to result in macrocyclic oligomers. To avoid the premature polymerization of methacrylate groups, the condensation groups usually have to be activated to assure a mild reaction for cyclization with the coupling monomers.
BisGMA is one of widely used dental resin and it contains two free radical polymerizable group, methacrylate and two hydroxyl groups. This turns BisGMA an ideal candidate for polymerizable macrocyclic oligomer, although the presence of BisGMA isomer would make more complicated to this approach. As shown in Scheme I, carbonyldiimidazol (CDI, 1), was used to selectively reacted with the secondary alcohol in BisGMA (2) to give an activated BisGMA, DIZ-BisGMA(3). It was isolated and the chemical structure of DIZ-BisGMA was fully characterized with FITR and NMR. Actually, according to the recent report by Davis et al of Courtlaulds, England, CDI and its intermediates could exhibit surprisingly specificity towards primary, secondary, tertiary functional groups, of the same type, during the controlled formation of various well-defined molecular sequence. Our idea is to adopt same chemistry of CDI and to activate the two secondary hydroxyl group. Furthermore, an activated precursor, DIZ-BisGMA, was made to react with various primary diols 1,10-decanediol, under a pseudo high-dilution condition, as shown in Scheme II. Both reactants were simultaneously charged into the system in a high-dilution condition via slowly, precisely controlled addition to ensure a favorable formation of cyclic product. Since the product, C10-CYCBGM (5), is accumulated with a final concentration of 0.02M, which is much higher than the classical high dilution condition (0.001M), this procedure is, therefore, referred as pseudo-high-dilution approach. Since imidazol is produced from both precursor and cyclization steps, a continuous process was successfully developed without direct separation of DIZ-BisGMA.
This is a Continuation Application which claims priority to U.S. Ser. No. 12/655,028 filed on Dec. 22, 2009, now abandoned, which claims priority to U.S. Ser. No. 12/381,781 filed on Mar. 16, 2009, now abandoned, which claims priority to U.S. Ser. No. 12/079,525 filed on Mar. 27, 2008, now abandoned, which in turn claims priority to U.S. Ser. No. 11/153,090 filed on Jun. 15, 2005, now abandoned, which in turn claims priority to provisional patent application Ser. No. 60/579,836 filed on Jun. 15, 2004, now abandoned.
Number | Name | Date | Kind |
---|---|---|---|
4131729 | Schmitt et al. | Dec 1978 | A |
4323348 | Schmitz-Josten et al. | Apr 1982 | A |
4323696 | Schmitz-Josten et al. | Apr 1982 | A |
4379695 | Orlowski et al. | Apr 1983 | A |
4407984 | Ratcliffe et al. | Oct 1983 | A |
4459193 | Ratcliffe et al. | Jul 1984 | A |
4644053 | Brunelle et al. | Feb 1987 | A |
4722947 | Thanawalla et al. | Feb 1988 | A |
4744827 | Winkel et al. | May 1988 | A |
5047261 | Moussa et al. | Sep 1991 | A |
5110893 | Fukuyama | May 1992 | A |
5321117 | Brunelle | Jun 1994 | A |
5444104 | Waknine | Aug 1995 | A |
5609675 | Noritake et al. | Mar 1997 | A |
5621119 | Podszun et al. | Apr 1997 | A |
5760142 | Klee | Jun 1998 | A |
5792821 | Bowen | Aug 1998 | A |
5846075 | Shu et al. | Dec 1998 | A |
5856374 | Ono et al. | Jan 1999 | A |
5886064 | Rheinberger et al. | Mar 1999 | A |
5944527 | Hasel | Aug 1999 | A |
5962703 | Moszner et al. | Oct 1999 | A |
5998499 | Klee et al. | Dec 1999 | A |
6022940 | Byerley et al. | Feb 2000 | A |
6031015 | Ritter et al. | Feb 2000 | A |
6037444 | Rannard et al. | Mar 2000 | A |
6043361 | Evans et al. | Mar 2000 | A |
6057460 | Moszner et al. | May 2000 | A |
6096903 | Moszner et al. | Aug 2000 | A |
6121344 | Angeletakis et al. | Sep 2000 | A |
6127450 | Angeletakis | Oct 2000 | A |
6147136 | Bissinger | Nov 2000 | A |
6177534 | Antonucci et al. | Jan 2001 | B1 |
6184339 | Stansbury et al. | Feb 2001 | B1 |
6187836 | Oxman et al. | Feb 2001 | B1 |
6204302 | Rawls et al. | Mar 2001 | B1 |
6232367 | Kobashigawa et al. | May 2001 | B1 |
6262142 | Wang et al. | Jul 2001 | B1 |
6344556 | Evans et al. | Feb 2002 | B1 |
6353040 | Subelka et al. | Mar 2002 | B1 |
6353061 | Klee et al. | Mar 2002 | B1 |
6376026 | Correll et al. | Apr 2002 | B1 |
6380347 | Lau et al. | Apr 2002 | B1 |
6384106 | Angeletakis | May 2002 | B1 |
6391940 | Blackwell et al. | May 2002 | B1 |
6395803 | Angeletakis | May 2002 | B1 |
6399037 | Pflug et al. | Jun 2002 | B1 |
6448301 | Gaddam et al. | Sep 2002 | B1 |
6495643 | Evans et al. | Dec 2002 | B1 |
6566413 | Weinmann et al. | May 2003 | B1 |
20020025993 | Klee et al. | Feb 2002 | A1 |
20020068771 | Klee et al. | Jun 2002 | A1 |
20020128347 | Blackwell et al. | Sep 2002 | A1 |
20030060535 | Moszner et al. | Mar 2003 | A1 |
20030125435 | Norling et al. | Jul 2003 | A1 |
20040077882 | Moszner et al. | Apr 2004 | A1 |
20040106741 | Kriessel et al. | Jun 2004 | A1 |
20050154199 | Whiteford et al. | Jul 2005 | A1 |
20060063854 | Jin et al. | Mar 2006 | A1 |
Number | Date | Country |
---|---|---|
9702787 | Jan 1997 | WO |
9917677 | Apr 1999 | WO |
0003688 | Jan 2000 | WO |
0195862 | Dec 2001 | WO |
2005123008 | Dec 2005 | WO |
Number | Date | Country | |
---|---|---|---|
20110152569 A1 | Jun 2011 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12655028 | Dec 2009 | US |
Child | 12912951 | US |